{"id":578501,"date":"2025-11-18T15:03:28","date_gmt":"2025-11-18T15:03:28","guid":{"rendered":"https:\/\/www.europesays.com\/uk\/578501\/"},"modified":"2025-11-18T15:03:28","modified_gmt":"2025-11-18T15:03:28","slug":"why-biosimilars-are-malaysias-next-health-investment-nst-online","status":"publish","type":"post","link":"https:\/\/www.europesays.com\/uk\/578501\/","title":{"rendered":"Why Biosimilars are Malaysia's next health investment – NST Online"},"content":{"rendered":"
    \n
  1. Why Biosimilars are Malaysia’s next health investment<\/a>  NST Online<\/li>\n
  2. EU Clears Path for Biosimilars in Diabetes & Bone Health<\/a>  Medscape<\/li>\n
  3. CHMP Positive Opinions for Denosumab & Insulin Glargine Biosims<\/a>  Pearce IP<\/li>\n
  4. EMA recommends approval for nine biosimilars<\/a>  Generics and Biosimilars Initiative<\/li>\n
  5. Biosimilars: a vital remedy for Europe\u2019s healthcare challenges<\/a>  Labiotech.eu<\/li>\n<\/ol>\n","protected":false},"excerpt":{"rendered":"Why Biosimilars are Malaysia’s next health investment  NST Online EU Clears Path for Biosimilars in Diabetes & Bone Health  Medscape…\n","protected":false},"author":2,"featured_media":578502,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[4315],"tags":[182377,1204,183126,105,1055,4326,183125,16,15,978,1823],"class_list":{"0":"post-578501","1":"post","2":"type-post","3":"status-publish","4":"format-standard","5":"has-post-thumbnail","7":"category-medication","8":"tag-biosimilars","9":"tag-cancer","10":"tag-dr-abdul-mueed-khan","11":"tag-health","12":"tag-malaysia","13":"tag-medication","14":"tag-nst-insight","15":"tag-uk","16":"tag-united-kingdom","17":"tag-us","18":"tag-world-health-organisation"},"share_on_mastodon":{"url":"https:\/\/pubeurope.com\/@uk\/115571314196951091","error":""},"_links":{"self":[{"href":"https:\/\/www.europesays.com\/uk\/wp-json\/wp\/v2\/posts\/578501","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.europesays.com\/uk\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.europesays.com\/uk\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/uk\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/uk\/wp-json\/wp\/v2\/comments?post=578501"}],"version-history":[{"count":0,"href":"https:\/\/www.europesays.com\/uk\/wp-json\/wp\/v2\/posts\/578501\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/uk\/wp-json\/wp\/v2\/media\/578502"}],"wp:attachment":[{"href":"https:\/\/www.europesays.com\/uk\/wp-json\/wp\/v2\/media?parent=578501"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.europesays.com\/uk\/wp-json\/wp\/v2\/categories?post=578501"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.europesays.com\/uk\/wp-json\/wp\/v2\/tags?post=578501"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}